The human genome harbors numerous subtle sequence variations, termed variants, which influence protein synthesis within cellular processes. Among these, only a minority exert deleterious effects on protein function, thereby contributing to pathological conditions. Identifying such pathogenic variants amidst the abundance of benign alterations represents a longstanding challenge in genomic medicine.
Prior methodologies, including genome-wide association…
AI
Ariel Ionescu, the scientist who co-founded Rinnerva Therapeutics and has spent years developing a truly innovative therapy for amyotrophic lateral sclerosis (ALS), sat down with Nicolae Tomescu. In this exclusive interview for SLA România – first published on NEUROOTS.co – Dr. Ionescu gives the straight answers to the questions that matter most to the ALS…
